UTAH MEDICAL PRODUCTS INC
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $13.8M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $254.0K | 1.8% |
| Dividends Paid | $3.6M | 25.8% |
| Other Financing | $7.6M | 55.3% |
| Net Cash Flow | $2.3M | 17.0% |